What is NDC 70069-025?

70069-025 is the product NDC for Dexamethasone Sodium Phosphate, Dexamethasone sodium phosphate 10 mg/mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dexamethasone Sodium Phosphate?

94 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dexamethasone Sodium Phosphate NDC 70069-025

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-025Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0025Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-025-10	7006900251070069002510	10 VIAL in 1 CARTON (70069-025-10) / 10 mL in 1 VIALMarketed from Jun 11, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Somerset Therapeutics, LLCNDC labeler code 70069
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211036
Marketing start: Jun 11, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70069-025_0fefe630-0e29-4d04-a083-eb3036f48100SPL ID 0fefe630-0e29-4d04-a083-eb3036f48100SPL set ID 5a1b0266-90c8-4176-a6b0-c4204d3c604eRxCUI 309696UNII AI9376Y64PUPC 0370069025109, 0370069025017
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470069002510 followed by a unit qualifier and the quantity

Package 70069-0025-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 14, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE A. Intravenous or intramuscular administration When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows: 1. Endocrine disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choic…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70069-025

What is NDC 70069-025?: 70069-025 is the product NDC for Dexamethasone Sodium Phosphate, Dexamethasone sodium phosphate 10 mg/mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dexamethasone Sodium Phosphate.
What is the active ingredient?: Dexamethasone sodium phosphate.
Who is the labeler?: Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dexamethasone Sodium Phosphate?: 94 other product NDCs are listed under this name. See all Dexamethasone Sodium Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dexamethasone Sodium Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	REMEDYREPACK INC.	70518-4372	70518-4372-00
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Armas Pharmaceuticals	72485-118	72485-0118-25
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Henry Schein, Inc.	0404-9795	00404-9795-30
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Henry Schein, Inc.	0404-9805	00404-9805-05
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Medical Purchasing Solutions, LLC.	71872-7347	71872-7347-01
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 4 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Sagent Pharmaceuticals	25021-052	25021-0052-0125021-0052-05
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Sagent Pharmaceuticals	25021-053	25021-0053-01
Dexamethasone sodium phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Micro Labs Limited	42571-432	42571-0432-4042571-0432-79
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, EmulsionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	76045-212	76045-0212-10
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	InjectionIntra-articular, Intralesional, Intramuscular, Intravenous, Soft tissue	Gland Pharma Limited	68083-607	68083-0607-25

All 95 Dexamethasone Sodium Phosphate NDCs

Other NDCs under ANDA 211036

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211036
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone Sodium Phosphate	Dexamethasone sodium phosphate 10 mg/mL	Injection, SolutionIntramuscular, Intravenous	Medical Purchasing Solutions, LLC	71872-7205